
CONMED CORP
CNMDNYSETrading Snapshot
- Day Range
- $607.35 β $620.88
- 52-Week Range
- $31.44 β $56.64
- Volume
- $4.26B
- Avg Volume
- $5.04B
- Shares Outstanding
- 30.0M
- Next Earnings
- Oct 22, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.37B
- Last Q Revenue
- $343M
- P/E Ratio
- 26.8
- P/S Ratio
- 1.1x
- EPS (TTM)
- $1.88
- Dividend Yield
- 0.40%
Why Investors Own CNMD
- βHigh-growth profile β revenue up +53.9% YoY with expanding US Equity exposure.
- βHealthy economics β 52% gross margin and 20% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About CONMED CORP
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
CONMED CORP tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift CNMD price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CONMED CORP announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.